{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Possibly Marketed Outside US
Source:
NCT04265950: Phase 4 Interventional Active, not recruiting HIV Infection
(2022)
Source URL:
First approved in 2014
Source:
BLA125508
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT04265950: Phase 4 Interventional Active, not recruiting HIV Infection
(2022)
Source URL:
First approved in 2014
Source:
BLA125508
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT04265950: Phase 4 Interventional Active, not recruiting HIV Infection
(2022)
Source URL:
First approved in 2014
Source:
BLA125508
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
First approved in 2014
Source:
Dr. Cellapy SR Premium Solution by GM Holdings Co., Ltd
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
Cosmeceutical Mask Pack by YBK Investment, INC
Source URL:
First approved in 2013
Source:
Cosmeceutical Mask Pack by YBK Investment, INC
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(2013)
Source URL:
First approved in 2013
Source:
21 CFR 352
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
M016
(2013)
Source URL:
First approved in 2013
Source:
M016
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
HERBALIFE SKIN 7 DAY RESULTS KIT
Source URL:
First approved in 2012
Source:
21 CFR 352
Source URL:
Class:
PROTEIN
Conditions:
Status:
Possibly Marketed Outside US
Source:
NCT01715493: Phase 4 Interventional Completed Chronic Obstructive Pulmonary Disease
(2012)
Source URL:
First approved in 2012
Source:
21 CFR 346
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
Dermaheal Cosmeceutical Mask Pack Plus by YBK Investment, INC
Source URL:
First approved in 2012
Source:
21 CFR 347
Source URL:
Class:
PROTEIN
